Skip to main content

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

David Rodriguez Luna

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

INVICTUS

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 247695.66
Reference: RD12/0014/0005
Duration: 01/01/2013 - 31/03/2017

Malalties neurovasculars

IP: Joan Montaner Villalonga
Collaborators: David Rodriguez Luna, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 72000
Reference: CM11/00087
Duration: 01/01/2012 - 31/12/2013

Síndrome de apneas del sueño e infarto cerebral silente en pacientes hipertensos

IP: José Alvarez Sabin
Collaborators: Gabriel Sampol Rubio, Alejandro Ferré Masó, David Rodriguez Luna, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 52030
Reference: PI11/01676
Duration: 01/01/2012 - 30/06/2015

European Stroke Research Network for Hypothermia (EUROHYP-1) Grant Agreement nº 278709

IP: Carlos Molina Cateriano
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Estela Sanjuan Menendez, Marc Ribó Jacobi, Maria Pilar Meler Amella, David Rodriguez Luna, Mª Ángeles Muchada López
Funding agency: EUROPEAN COMMISSION
Funding: 655474
Reference: 'EUROHYP-1_FP7HEALTH2011
Duration: 01/02/2012 - 31/07/2018

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Sara  López  Branchadell

Sara López Branchadell

Research technician
Read more
Josep Sanjose Puig

Josep Sanjose Puig

Tècnic/a Superior Recerca
Clinical Research Development Directorate
Read more
Ester Mateos Mullor

Ester Mateos Mullor

P. Management and Admin. Technical specialist
Quality, Processes and Document Management Unit
Digital Transformation Directorate
Read more
Ignasi Cardona Pascual

Ignasi Cardona Pascual

Senior researcher
Basic, Translational and Clinical Pharmacy Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.